Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 22, 2022 - Issue 2: Biosimilars
Submit an article Journal homepage
286
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group

Fatma Gül Demirkana Department of Pediatric Rheumatology, Istanbul University, Istanbul School of Medicine, İstanbul, TurkeyORCID Iconhttps://orcid.org/0000-0001-9950-2489View further author information
ORCID Icon,
Kadir Ulub Department of Pediatric Rheumatology, University of Health Sciences, Ümraniye Research and Training Hospital, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-8197-6077View further author information
ORCID Icon,
Kübra Öztürkc Department of Pediatric Rheumatology, Istanbul Medeniyet University, School of Medicine, Goztepe Research and Training Hospital, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0003-0466-0228View further author information
ORCID Icon,
Şerife Gül Karadağd Department of Pediatric Rheumatology, University of Health Sciences, Bakırköy Dr. SadiKonuk Training and Research Hospital, İstanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-3232-0055View further author information
ORCID Icon,
Semanur Özdele Department of Pediatric Rheumatology, University of Health Sciences, Dr. Sami Ulus Obstetrics and Gynecology, Pediatric Health and Disease Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0001-5602-4595View further author information
ORCID Icon,
Hafize Emine Sönmezf Department of Pediatric Rheumatology, Kocaeli University, Kocaeli School of Medicine, Kocaeli, TurkeyORCID Iconhttps://orcid.org/0000-0002-9186-3068View further author information
ORCID Icon,
Figen Çakmaka Department of Pediatric Rheumatology, Istanbul University, Istanbul School of Medicine, İstanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-1667-2480View further author information
ORCID Icon,
Ferhat Demirb Department of Pediatric Rheumatology, University of Health Sciences, Ümraniye Research and Training Hospital, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0001-9801-925XView further author information
ORCID Icon,
Betül Sözerib Department of Pediatric Rheumatology, University of Health Sciences, Ümraniye Research and Training Hospital, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-5079-5644View further author information
ORCID Icon &
Nuray Aktay Ayaza Department of Pediatric Rheumatology, Istanbul University, Istanbul School of Medicine, İstanbul, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3594-7387View further author information
ORCID Icon show all
Pages 197-202 | Received 13 Jul 2021, Accepted 01 Nov 2021, Published online: 16 Nov 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kadir Ulu, Mustafa Çakan, Şengül Çağlayan, Ramazan Emre Yiğit, Ferhat Demir, Taner Coşkuner, Esra Kardeş & Betül Sözeri. (2023) Real-life data on efficacy and safety of original Adalimumab and biosimilar Adalimumab (ABP 501) in pediatric rheumatic diseases. Expert Opinion on Biological Therapy 23:8, pages 833-839.
Read now

Articles from other publishers (4)

Maria Tarsia, Antonio Vitale, Carla Gaggiano, Jurgen Sota, Anna Maselli, Chiara Bellantonio, Silvana Guerriero, Rosanna Dammacco, Francesco La Torre, Gaafar Ragab, Mohamed Tharwat Hegazy, Alex Fonollosa, Maria Pia Paroli, Emanuela Del Giudice, Maria Cristina Maggio, Marco Cattalini, Lampros Fotis, Giovanni Conti, Angela Mauro, Adele Civino, Federico Diomeda, Alejandra de-la-Torre, Carlos Cifuentes-González, Samar Tharwat, José Hernández-Rodríguez, Verónica Gómez-Caverzaschi, Laura Pelegrín, Kalpana Babu, Vishali Gupta, Francesca Minoia, Piero Ruscitti, Stefania Costi, Luciana Breda, Saverio La Bella, Alessandro Conforti, Maria Antonietta Mazzei, Ester Carreño, Rana Hussein Amin, Salvatore Grosso, Bruno Frediani, Gian Marco Tosi, Alberto Balistreri, Luca Cantarini & Claudia Fabiani. (2024) Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry. Ophthalmology and Therapy 13:3, pages 761-774.
Crossref
. (2022) Adalimumab/etanercept. Reactions Weekly 1934:1, pages 17-17.
Crossref
Xuefeng Xu, Xiaohui Liu, Wenjie Zheng, Jihong Xiao, Xiaozhong Li, Ling Wu, Lixia Zou, Qian Ouyang, Yaoyao Shangguan, Kezhao Lin, Xiaomei Dai, Yuanling Chen, Yiping Xu, Jianqiang Wu & Meiping Lu. (2022) Efficacy and safety of etanercept biosimilar rhTNFR-Fc in Chinese patients with juvenile idiopathic arthritis: An open-label multicenter observational study. Frontiers in Pediatrics 10.
Crossref
Fatma Gül Demirkan, Hafize Emine Sönmez, Lovro Lamot, Özlem Akgün, Betül Sözeri & Nuray Aktay Ayaz. (2022) Embracing Change: An International Survey Study on the Beliefs and Attitudes of Pediatric Rheumatologists Towards Biosimilars. BioDrugs 36:3, pages 421-430.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.